A pathogenic threshold of virus load defined in simian immunodeficiency virus- or simian-human immunodeficiency virus-infected macaques

被引:138
作者
Ten Haaft, P
Verstrepen, B
Überla, K
Rosenwirth, B
Heeney, J
机构
[1] Biomed Primate Res Ctr, Dept Virol, NL-2280 GH Rijswijk, Netherlands
[2] Univ Erlangen Nurnberg, Inst Klin & Mol Virol, D-91054 Erlangen, Germany
关键词
D O I
10.1128/JVI.72.12.10281-10285.1998
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
To determine if a specific pathogenic threshold of plasma viral RNA could be defined irrespective of virus strain, RNA levels in the plasma of more than 50 infected rhesus macaques (Macaca mulatta) were measured. Animals were inoculated intravenously with either simian immunodeficiency virus (SN) or simian-human immunodeficiency virus (SHIV strains of known pathogenic potential (SIV8980, SIVsmm-3, SIVmac32H/J5, SIVmac32H/1XC, reverse transcriptase-SHIV, SHIV89.6p) or with attenuated strains (SHIVW6.1D, SHIVsf13, SHIVhan-2, SIVmac Delta ncf, SHIVsf33). In animals inoculated with nonpathogenic strains, shortly after the primary peak of viremia viral RNA levels declined and remained below 10(4) RNA equivalents/ml of plasma between 6 and 12 weeks postinoculation. Animals infected with documented pathogenic strains maintained viral RNA levels higher then 10(5) RNA equivalents/ml of plasma. In animals infected with strains with low virulence, a decline in plasma RNA levels was observed, but with notable individual variation. Our results demonstrate that the disease-causing potential was predicted and determined by a threshold plasma virus load which remained greater than 10(5) RNA equivalents/ml of plasma 6 to 12 weeks after inoculation. A threshold virus load value which remained below 10(4) RNA equivalents/ml of plasma was indicative of a nonpathogenic course of infection.
引用
收藏
页码:10281 / 10285
页数:5
相关论文
共 34 条
[1]   Comparison of in vitro and in vivo infectivity of different clade B HIV-1 envelope chimeric simian/human immunodeficiency viruses in Macaca mulatta [J].
Bogers, WMJM ;
Dubbes, R ;
tenHaaft, P ;
Niphuis, H ;
ChengMayer, C ;
StahlHennig, C ;
Hunsmann, G ;
Kuwata, T ;
Hayami, M ;
Jones, S ;
Ranjbar, S ;
Almond, N ;
Stott, J ;
Rosenwirth, B ;
Heeney, JL .
VIROLOGY, 1997, 236 (01) :110-117
[2]  
BOGERS WMJM, 1995, AIDS, V9, pF13
[3]   Human immunodeficiency virus drug therapy and virus load [J].
Bonhoeffer, S ;
Coffin, JM ;
Nowak, MA .
JOURNAL OF VIROLOGY, 1997, 71 (04) :3275-3278
[4]   HIV-1 ENVELOPE-ELICITED NEUTRALIZING ANTIBODY-TITERS CORRELATE WITH PROTECTION AND VIRUS LOAD IN CHIMPANZEES [J].
BRUCK, C ;
THIRIART, C ;
FABRY, L ;
FRANCOTTE, M ;
PALA, P ;
VANOPSTAL, O ;
CULP, J ;
ROSENBERG, M ;
DEWILDE, M ;
HEIDT, P ;
HEENEY, J .
VACCINE, 1994, 12 (12) :1141-1148
[5]   HOST RANGE, REPLICATIVE, AND CYTOPATHIC PROPERTIES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ARE DETERMINED BY VERY FEW AMINO-ACID CHANGES IN TAT AND GP120 [J].
CHENGMAYER, C ;
SHIODA, T ;
LEVY, JA .
JOURNAL OF VIROLOGY, 1991, 65 (12) :6931-6941
[6]   Weakened SIV vaccine still kills [J].
Cohen, I .
SCIENCE, 1997, 278 (5335) :24-25
[7]   PROTECTIVE EFFECTS OF A LIVE ATTENUATED SIV VACCINE WITH A DELETION IN THE NEF GENE [J].
DANIEL, MD ;
KIRCHHOFF, F ;
CZAJAK, SC ;
SEHGAL, PK ;
DESROSIERS, RC .
SCIENCE, 1992, 258 (5090) :1938-1941
[8]   SEQUENCE-ANALYSIS AND ACUTE PATHOGENICITY OF MOLECULARLY CLONED SIVSMM-PBJ14 [J].
DEWHURST, S ;
EMBRETSON, JE ;
ANDERSON, DC ;
MULLINS, JI ;
FULTZ, PN .
NATURE, 1990, 345 (6276) :636-640
[9]   Protection of SIVmac-infected macaque monkeys against superinfection by a simian immunodeficiency virus expressing envelope glycoproteins of HIV type 1 [J].
Dunn, CS ;
Hurtrel, B ;
Beyer, C ;
Gloeckler, L ;
Ledger, TN ;
Moog, C ;
Kieny, MP ;
Mehtali, M ;
Schmitt, D ;
Gut, JP ;
Kirn, A ;
Aubertin, AM .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1997, 13 (11) :913-922
[10]   The history of simian AIDS [J].
Gardner, MB .
JOURNAL OF MEDICAL PRIMATOLOGY, 1996, 25 (03) :148-157